info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143188 |
| CAS No | NA |
| Mol.F. | C10H14N4O2S |
| Mol.Wt. | 254.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143189 |
| CAS No | NA |
| Mol.F. | C9H14N4OS |
| Mol.Wt. | 226.30 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143190 |
| CAS No | NA |
| Mol.F. | C10H16N4O2S |
| Mol.Wt. | 256.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143191 |
| CAS No | NA |
| Mol.F. | C20H31N7OS2 |
| Mol.Wt. | 449.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143192 |
| CAS No | NA |
| Mol.F. | C11H16N4O3S |
| Mol.Wt. | 284.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143193 |
| CAS No | NA |
| Mol.F. | C45H50N8O8S |
| Mol.Wt. | 863.0 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143194 |
| CAS No | NA |
| Mol.F. | C12H16N4O6S |
| Mol.Wt. | 344.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143195 |
| CAS No | NA |
| Mol.F. | C33H34ClN5O4 |
| Mol.Wt. | 600.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143196 |
| CAS No | NA |
| Mol.F. | C26H23FN6O8S |
| Mol.Wt. | 598.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143197 |
| CAS No | NA |
| Mol.F. | C15H10FN3O4 |
| Mol.Wt. | 315.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143198 |
| CAS No | NA |
| Mol.F. | C34H36ClN5O4 |
| Mol.Wt. | 614.1 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143199 |
| CAS No | NA |
| Mol.F. | C78H82Cl2N12O10S |
| Mol.Wt. | 1450.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143200 |
| CAS No | NA |
| Mol.F. | C45H49ClN8O8S |
| Mol.Wt. | 897.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143201 |
| CAS No | NA |
| Mol.F. | C45H48ClN9O9S |
| Mol.Wt. | 926.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143202 |
| CAS No | NA |
| Mol.F. | C45H48ClN9O9S |
| Mol.Wt. | 926.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143203 |
| CAS No | NA |
| Mol.F. | C30H32N8O8S |
| Mol.Wt. | 664.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
